What is the difference between Inflectra and Remicade?

Q: What is the difference between Inflectra and Remicade?

Inflectra (infliximab-dyyb) is a biosimilar to Remicade (infliximab). They belong to the same class of drugs called tumor necrosis factor (TNF) alfa inhibitors. Inflectra can be prescribed for the same uses as Remicade, including rheumatoid arthritis, Crohn’s disease, ankylosing spondylitis, ulcerative colitis, psoriatic arthritis, and plaque psoriasis.

Official answer

by Drugs.com

Key Points

Inflectra (infliximab-dyyb) is a biosimilar to Janssen’s Remicade (infliximab). Inflectra and Remicade belong to the class of drugs called tumor necrosis factor (TNF) alpha inhibitors.

Inflectra can be prescribed for the same uses as Remicade, including rheumatoid arthritis, Crohn’s disease, ankylosing spondylitis, ulcerative colitis, psoriatic arthritis, and plaque psoriasis. It is often used when other medicines have not been effective.

Both Inflectra and Remicade come as an intravenous (IV) powder for injection.

A biosimilar must have no clinically meaningful safety or effectiveness differences from the reference product, but it is not considered identical like a generic product.

Related: What Are Biosimilars? Top Facts You May Not Know

Inflectra, approved in 2016, is manufactured by Celltrion-Pfizer, while Remicade, the reference product, was first approved in 1998 and is made by Janssen. Inflectra was the first biosimilar to Remicade.

How does infliximab work?

Infliximab blocks the protein called tumor necrosis factor-alfa (TNF alpha). People with certain inflammatory diseases, like psoriasis or rheumatoid arthritis, have too much TNF-alpha. This can cause the immune system to attack healthy tissues of the body. Infliximab can help block the damage caused in your body by too much TNF-alpha.

Other infliximab biosimilar brands include:

Avsola (infliximab-axxq) from Amgen, approved Dec. 2019

Ixifi (infliximab-qbtx) from Pfizer, approved Dec. 2017

Renflexis (infliximab-abda) from Samsung Bioepis, approved April 2017

How do costs compare between Inflectra and Remicade?

Inflectra, as a biosimilar, is slightly less expensive than Remicade. Inflectra costs about $997 per 100 mg vial while Remicade costs about $1,229 for the same amount.

For additional information, see the overview: Comparing Inflectra vs Remicade

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.